Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: a systematic review

Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: a systematic review

Newborns are particularly susceptible to off-label and unlicensed (OLUL) drug treatments, especially in the intensive care setting, inferring from dosing regimens and indications supported in older populations and built on non-neonatal pathophysiology. This use leads to unpredictable drug effectiven...

Full description

Bibliographic Details
Main Authors: Fábio Reis, Rita Pissarra, Henrique Soares, Paulo Soares, Hercília Guimarães
Format: Article
Language:English
Published: Hygeia Press di Corridori Marinella 2021-07-01
Series:Journal of Pediatric and Neonatal Individualized Medicine
Subjects:
newborn
off-label
unlicensed
prescribing
drug
neonatal intensive care unit
Online Access:https://jpnim.com/index.php/jpnim/article/view/1190

Internet

https://jpnim.com/index.php/jpnim/article/view/1190

Similar Items